
Erremedio Pharmaceuticals (Opc) Private Limited
Founded in 2019 and headquartered in Maharashtra, India.
Founded in 2019 and headquartered in Maharashtra, India.
Nagpur, Maharashtra, India
+91-XXXXXXXXXX
U85300MH2019OPC323319
323319
29 Mar 2019
-
-
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Akshay Dakhane ![]() | Director | 29-Mar-2019 | Current |
Enhance accessibility to Erremedio Pharmaceuticals (Opc)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Erremedio Pharmaceuticals (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Akshay Dakhane is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Erremedio Pharmaceuticals (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Erremedio Pharmaceuticals (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Erremedio Pharmaceuticals (Opc)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Akshay Gangadhar Dakhane was appointed as a Director was appointed as a Director on 29 Mar 2019 & has been associated with this company since 6 years 2 months .
Erremedio Pharmaceuticals (Opc) Private Limited was registered on 29 Mar 2019 with Roc Mumbai & aged 6 years 2 months as per MCA records.
Erremedio Pharmaceuticals (Opc) Private Limited was incorporated on 29 Mar 2019.
The authorized share capital of Erremedio Pharmaceuticals (Opc) Private Limited is ₹ 0.50 M and paid-up capital is ₹ 50.00 K .
Currently 1 director is associated with Erremedio Pharmaceuticals (Opc) Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Erremedio Pharmaceuticals (Opc) Private Limited is Block No. 3, Khullar Chamber Munje Square, Nagpur, Maharashtra, India, 440012.
The corporate identification number (CIN) of Erremedio Pharmaceuticals (Opc) Private Limited is U85300MH2019OPC323319 and the company number is 323319 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.